3-Chlorophenylboronic acid

We are 3-Chlorophenylboronic acid CAS:63503-60-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 3-Chlorophenylboronic acid
Other Name:
3-Chlorophenylboronic acid
3-chloro-phenyl boronic acid
3-CHLOROPHENYLBORNIC ACID
M-CHLOROPHENYLBORONIC ACID
3-chlorophenylboric acid
3-Chlorophenyl-dihydroxyborane
CAS No: 63503-60-6
MF: C6H6BClO2
MW: 156.37500
Density: 1.32 g/cm3
Boiling point: 311.4ºC at 760 mmHg
Melting point: 185-189 °C(lit.)
Flash point: 142.1ºC
Refractive index: 1.557
UN Number: UN3271
UN Proper Shipping Name: ADR/RID: ETHERS, N.O.S.
Transport hazard class: 3
Packing group: III
 
Specification
Appearance: White to light yellow crystalline powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Applicationd as an intermediate of Vadadustat.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

3-Chlorophenylboronic acid


Related News: However, pharmaceutical intermediates are subdivided into primary intermediates and advanced intermediates. Because primary intermediate suppliers can only provide simple intermediate production, they are at the front end of the industrial chain. The pressure of competition and price is the greatest. The price fluctuations of basic chemical raw materials have a greater impact on them.96-96-8 The CTSuccess service uses Catalent’s proprietary StartScoreTM evaluation tool to calculate the complexity of a potential clinical project across more than a dozen specific and objective study characteristics.Vinyltrimethoxysilane Active pharmaceutical ingredients directly impact disease.Furfuryl thioacetate CAS:13678-68-7 Active pharmaceutical ingredients directly impact disease.As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.

Related Products
Product Name
1-Bromo-2,5-difluorobenzene View Details
D-Isoleucine View Details
2,6-Dihydroxybenzoic acid View Details
(2R,3S)-3-Phenylisoserine manufacturer 2-bromo-1-[4-[4-(2-bromoacetyl)phenyl]phenyl]ethanone manufacturer 3-Hydroxy-2-methylpyridine manufacturer [dimethylamino-(2-oxopyridin-1-yl)oxymethylidene]-dimethylazanium,hexafluorophosphate manufacturer 2-Cyano-3-Nitropyridine manufacturer